Amit Sehrawat

25PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 29, 2026
Real-world efficacy and safety of trastuzumab emtansine biosimilar (UJVIRA®) in early and metastatic HER2-positive breast cancer: a multicenter pooled retrospective analysis from India.

|Aug 20, 2026
Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin for Muscle-Invasive Bladder Cancer: Real-World Feasibility and Safety in a Resource-Constrained Setting.

|Aug 20, 2026
Feasibility and safety of accelerated MVAC (aMVAC) in geriatric patients with muscle-invasive bladder cancer.

|May 27, 2026
Primary Platinum-Resistant Ovarian Cancer: Clinicopathologic Correlates and Outcomes From a Multicenter Prospective Indian Registry.

|Apr 27, 2026
"Treatment Patterns and Survival Outcomes in Periampullary Carcinoma: A Multicentric Retrospective Study from the Indian Subcontinent".

|Feb 07, 2026
Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India.

Susheel Kumar Yeshala, Soumya Surath Panda, Lalatendu Moharana

Pageof 5

Frequent Collaborators

19 joint publications

Deepak Sundriyal

7 joint publications

Laltendu Moharana

6 joint publications

Ujjawal Shriwastav

6 joint publications

Mayank Kapoor